<GENX> DOUBLE LUMEN NEEDLE

{0}------------------------------------------------ <genX> international, Inc. 510(K) Premarket Notification Re: K991020 Double Lumen Needle ## 510K Summary K991020 - a) DEVICE NAME <genX> Double Lumen Needle Proprietary Name: Classification Name: Assisted Reproduction Needles b) ESTABLISHMENT REGISTRATION No .: 9003605 <genX> international, Inc. 170 Fort Path Road Madison, CT 06443 Tel: 203-245-4901 Fax: 203-245-4994 > Contact Individual: Michael D. Cecchi President - CLASSIFICATION: Class II c) Assisted Reproductive Needle Product: <genX> Double Lumen Needle Procode: 85 MQE CFR#: 884.6100 ## d) PERFORMANCE STANDARDS Performance Standards under Section 514 of the ACT have not been developed for this device. However, Special controls have been identified by the FDA to provide reasonable assurance of safety and effectiveness of the device in assisted reproductive procedures. - PROPOSED LABELS, LABELING, AND ADVERTISING e) The proposed labeling and instruction material is included in this package in the appropriate section. - 1) DESCRIPTION {1}------------------------------------------------ The <genX> Double Lumen Needle is intended to obtain gametes from the bodv. . The catalog number is GNDL-632 The basic design is two concentric stainless steel needle tubing of 32 cm in exposed length, forming the "dual lumen". The outer tubing has the point, the inner is flat. They are attached to a hub of polycarbonate designed especially for this purpose. The outer diameter of the outer needle tube is 16 gauge. Attached to the hub are two lengths of tubing. One is attached to the rear of the needles. which allows the gametes to be aspirated into a collection test tube, and the second length is attached to the flush port on the side. This second port is attached to a syringe, which allows the operator to inject media into the follicle to allow "flushing" - g) SUBSTANTIALLY EQUIVALENT The Double Lumen Needle is substantially equivalent to several products currently marketed in the US. See the appropriate section for the comparisons. (Section 2) h) STERILIZATION PROCEDURES AND FACILITIES All needles manufactured, will be Gamma Irradiated by and according to the guidelines in place. Dosage: 2.5 Mrad Sterility Assurance Level (SAL): of (10 to the -6 ) After sterilization the contractor will issue a "Certificate of Sterilization". Validation assurance is in accordance with ANSI / AAMI / ISO 11137-1994 Standards. See Section 11.0 {2}------------------------------------------------ Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Michael D. Cecchi President <genX> International, Inc. 170 Fort Path Road, Unit 14 Madison, CT 06443 Re: K991020 <genX> Double Lumen Needle Dated: June 5, 1999 Received: June 21, 1999 Regulatory Class: II 21 CFR §884.6100/Procode: 85 MQE Dear Mr. Cecchi: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class III (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4613. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the requlation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html". Sincerely yours. CAPT Daniel G. Schultz, M.D. Acting Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure Image /page/2/Picture/13 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a stylized symbol. The symbol consists of three abstract shapes that resemble human profiles or stylized wings, stacked on top of each other. d 1999 SEP {3}------------------------------------------------ <genX> international, Inc. 510(K) Premarket Notification B.1.0 ## INDICATIONS FOR USE 510 (k) Number ( if known )_ 991020 Device Names: <genX> Double Lumen Neeïdle Indication for Use: "Used to obtain gamete from the body" (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED ) | Concurrence of CDRH, Office of Device Evaluation ( ODE ) | | |----------------------------------------------------------|---------| | (Division Sign-Off) | | | Division of Reproductive, Abdominal, ENT, | | | and Radiological Devices | | | 510(k) Number | K991020 | | Prescription Use | X | | Over-the Counter Use | |